Prevalence of transradial coronary angiography and intervention in China: Report from the Transradial coronary intervention Registration Investigation in China (TRI-China)
Protective role of statins in patients with acute coronary syndrome aged ≥ 75 years with low LDL-C who underwent percutaneous coronary intervention.
Autorzy :
Bu C; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Zhao Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Ma H; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Han H; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Yang S; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Shi D; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Liu Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Fang Z; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Wang Z; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Ma Q; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Hu B; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Yang Q; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Li Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Liu R; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Nie B; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China. Zhou Y; Department of Cardiology, Beijing An zhen Hospital, Capital Medical University, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2014 Aug; Vol. 65 (7), pp. 590-5. Date of Electronic Publication: 2013 Aug 28.
Effect of remote ischemic preconditioning in the elderly patients with coronary artery disease with diabetes mellitus undergoing elective drug-eluting stent implantation.
Autorzy :
Xu X; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Zhou Y; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China . Luo S; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China Capital Medical University School of Rehabilitation Medicine, China Rehabilitation Research Centre, Beijing, China. Zhang W; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Zhao Y; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Yu M; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Ma Q; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Gao F; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Shen H; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Zhang J; Department of Cardiology, An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Pokaż więcej
Źródło :
Angiology [Angiology] 2014 Sep; Vol. 65 (8), pp. 660-6. Date of Electronic Publication: 2013 Oct 24.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
High clopidogrel dose in patients with chronic kidney disease having clopidogrel resistance after percutaneous coronary intervention.
Autorzy :
Liang J; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Wang Z; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Shi D; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Liu Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Zhao Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Han H; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Li Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Liu W; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Zhang L; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Yang L; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China. Zhou Y; Department of Cardiology, Anzhen Hospital, Capital Medical University, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2015 Apr; Vol. 66 (4), pp. 319-25. Date of Electronic Publication: 2014 Jun 08.
Percutaneous Coronary Intervention Rates and Associated Independent Predictors for Progression of Nontarget Lesions in Patients With Diabetes Mellitus After Drug-Eluting Stent Implantation.
Autorzy :
Wang L; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Zhou Y; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. . Peng P; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Xu X; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Yang S; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Liu W; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Han H; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Jia D; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Wang J; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Ji Q; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Ge H; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Liu Y; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Shi D; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China. Zhao Y; Department of Cardiology, Beijing An Zhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing, China.
Pokaż więcej
Źródło :
Angiology [Angiology] 2016 Jan; Vol. 67 (1), pp. 12-20. Date of Electronic Publication: 2015 Apr 20.
Insulin Resistance Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Elective Coronary Intervention.
Autorzy :
Li Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China. Liu Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China. Shi D; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China. Yang L; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China. Liang J; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China. Zhou Y; Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2016 Feb; Vol. 67 (2), pp. 139-45. Date of Electronic Publication: 2015 Apr 05.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Women With Early Menopause Have Higher Rates of Target Lesion Revascularization After Percutaneous Coronary Intervention.
Autorzy :
Zhang L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Wang Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Liu X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Zhou Z; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Zhao Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Shi D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Liu Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Liang J; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Yang L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Chai M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China. Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, The Key Laboratory of Remodeling-related Cardiovascular Disease, Ministry of Education, Beijing 100029, China .
Pokaż więcej
Źródło :
Angiology [Angiology] 2016 Apr; Vol. 67 (4), pp. 311-6. Date of Electronic Publication: 2015 Jun 01.
Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
Autorzy :
Yang Q; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Wang Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Liu J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Liu J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Hao Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Smith SC Jr; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Huo Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Fonarow GC; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Ma C; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Ge J; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Taubert KA; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Morgan L; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Guo Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Wang W; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Zhou Y; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). Zhao D; From the Department of Epidemiology (Q.Y., Y.W., Jing Liu, Jun Liu, Y.H., Y.G., W.W., D.Z.) and Department of Cardiology (Q.Y., C.M., Y.Z.), Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, China; Department of Cardiology, University of North Carolina, Chapel Hill (S.C.S.); Department of Cardiology, Peking University First Hospital, China (Y.H.); Department of Cardiology, University of California, Los Angeles (G.C.F.); Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China (J.G.); Department of International Science, American Heart Association, Basel, Switzerland (K.A.T.); and International Quality Improvement Department, American Heart Association, Dallas, TX (L.M.). .
CYP2C19 genotype and adverse cardiovascular outcomes after stent implantation in clopidogrel-treated Asian populations: A systematic review and meta-analysis.
Autorzy :
Xi Z; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China. Fang F; b Sleep Center , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China. Wang J; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China. AlHelal J; c International School of Capital Medical University , Beijing , China. Zhou Y; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China. Liu W; a Department of Cardiology , Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease , Beijing , China.
Pokaż więcej
Źródło :
Platelets [Platelets] 2019; Vol. 30 (2), pp. 229-240. Date of Electronic Publication: 2017 Dec 19.
Safety and efficacy of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: One-year results from a prospective patient-level pooled analysis of NeoVas trials.
Autorzy :
Xu K; General Hospital of Northern Theater Command, Shenyang, Liaoning, China. Fu G; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. Xu B; State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Centre for Coronary Heart Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Zhou Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. Su X; Department of Cardiology, Wuhan Asia Heart Hospital, Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China. Liu H; Department of Cardiology, Chinese Armed Police Force General Hospital, Beijing, China. Zhang Z; Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China. Yu B; Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education, Harbin, China. Wang X; General Hospital of Northern Theater Command, Shenyang, Liaoning, China. Han Y; General Hospital of Northern Theater Command, Shenyang, Liaoning, China.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
W koszyku znajdują się zamówienia
W koszyku znajdują się zamówienia do wysłania. Czy chcesz wysłać je do realizacji?
